The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Will Be The Estimated Market Valuation Of The Pharma Microbiology Testing Kits Market By The End Of 2030?
The pharma microbiology testing kits market has shown significant growth in recent years. Its valuation is anticipated to rise from $7.26 billion in 2025 to $7.94 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.4%. This historical expansion can be attributed to several factors, including pharmaceutical quality regulations, the increasing production of biologics, greater awareness of contamination risks, the expansion of vaccine manufacturing, and the necessity for GMP compliance requirements.
The pharma microbiology testing kits market size is projected to experience swift expansion over the coming years. It is anticipated to reach $11.98 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 10.8%. This expansion during the forecast period is driven by factors such as the growth in the biopharmaceutical pipeline, the increasing adoption of rapid testing technology, heightened regulatory stringency, the expansion of contract manufacturing, and the automation of quality control processes. Key developments expected during this period include a greater frequency of sterility testing, an uptick in the use of rapid microbial detection methods, the broadening of environmental monitoring initiatives, a surging demand for ready-to-use test kits, and the outsourcing of microbiology testing services.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2487&type=smp
What Major Growth Drivers Are Shaping The Outlook Of The Pharma Microbiology Testing Kits Market?
The increasing occurrence of infectious diseases is anticipated to drive the expansion of the pharma microbiology testing kits market in the future. These diseases are health conditions resulting from disease-causing microorganisms, including bacteria, viruses, fungi, or parasites, which can spread directly or indirectly between individuals. The frequency of infectious disease cases is escalating because of greater travel, which helps pathogens quickly disseminate globally. Pharma microbiology testing kits assist in diagnosing infectious diseases by offering precise and swift pathogen identification, proving crucial for prompt clinical judgments. These kits enhance laboratory effectiveness through reliable testing capabilities and by supporting successful treatment and outbreak control. For example, in February 2024, data from the UK Health Security Agency, a government body based in the UK, indicated that tuberculosis cases (a communicable bacterial infection mainly affecting the lungs) in England climbed to 4,850 in 2023, representing a 10.7% rise from 4,380 cases recorded in 2022. Consequently, the increasing spread of infectious diseases is fueling the expansion of the pharma microbiology testing kits market.
Which Segment Classifications Shape The Pharma Microbiology Testing Kits Market?
The pharma microbiology testing kits market covered in this report is segmented –
1) By Product: Consumables, Equipment
2) By Test: Endotoxin Testing, Sterility Testing, Microbial Examination, Environmental Monitoring, Other Tests
3) By End User: Hospitals And Diagnostic Centers, Custom Lab Service Providers, Academic And Research Institutes
Subsegments:
1) By Consumables: Media and Reagents, Test Kits, Sample Collection Containers
2) By Equipment: Incubators, Autoclaves, Microbial Identification Systems
How Are Trends Impacting The Pharma Microbiology Testing Kits Market?
Leading companies in the pharmaceutical microbiology testing kits market are increasingly concentrating on implementing innovative technologies, such as artificial intelligence-powered software, to improve operational efficiency, enhance diagnostic precision, and streamline laboratory workflows. In this context, artificial intelligence-powered software denotes advanced algorithms designed to analyze intricate data from diagnostic instruments, thereby assisting in the detection and identification of pathogens. For example, in May 2023, Becton, Dickinson, and Company, a US-based medical device company, secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new BD Kiestra MRSA Imaging Application, which uses artificial intelligence (AI) to improve the diagnosis of Methicillin-resistant Staphylococcus aureus (MRSA). This application automates the inspection of Petri dishes, a task typically demanding significant labor and time. It analyzes bacterial growth on BBL CHROMagar MRSA II plates and can swiftly identify specimens showing no substantial growth, facilitating faster processing and the prompt release of negative results.
Which Companies Are Expanding Their Footprint In The Pharma Microbiology Testing Kits Market?
Major companies operating in the pharma microbiology testing kits market are F. Hoffmann-La Roche AG, Becton Dickinson and Company, Abbott Laboratories, ThermoFisher Scientific, SGS SA, Toxikon Corp., Pace Analytical Services, Boston Analytics, Charles River Laboratories International, Nelson Laboratories, Siemens healthcare AG, Hologic Inc., Neogen Corporation, Shimadzu Corporation, Merck KGaA, Agilent TechnologiesInc., QIAGEN N.V., Bruker Corporation, bioMérieux SA, Lucideon, Lonza Group AG, MilliporeSigma, Hardy Diagnostics, Sartorius AG, 3M Company, Waters Corporation, PerkinElmer Inc., Luminex Corporation
Read the full pharma microbiology testing kits market report here:
Which Regions Are Projected To Dominate The Pharma Microbiology Testing Kits Market In The Coming Years?
North America was the largest region in the pharma microbiology testing kits market in 2025. Western Europe was the second-largest region in the global pharma microbiology testing kits market report. The regions covered in the pharma microbiology testing kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Pharma Microbiology Testing Kits Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2487&type=smp
Browse Through More Reports Similar to the Global Pharma Microbiology Testing Kits Market 2026, By The Business Research Company
Rapid Microbiology Testing Kits Market Report 2026
Drug Screening Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report
Antimicrobial Susceptibility Testing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model